Periostitis ossificans and sclerosing osteomyelitis are rare subtypes of non suppurative chronic osteomyelitis in which there is, additionally, a proliferation of periosteum leading to bony deposition secondary to a mild chronic infection making their diagnosis difficult. The authors report two clinical cases and try to release criteria helping to discern them because the prognosis and therapeutic management of these affections are different.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
A Case of Diffuse Sclerosing Osteomyelitis (DSO) Initially Diagnosed as Bacterial Mandibular Osteomyelitis and Successfully Treated With Bisphosphonate Administration (Ibandronate).
Cureus
December 2024
Department of Oral and Maxillofacial Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, JPN.
Diffuse sclerosing osteomyelitis (DSO) is a non-bacterial disease of the jawbone, characterized by intermittent pain, swelling, and a mixture of osteosclerosis and osteolysis on radiographs. Its etiology remains unclear, and a standard treatment, based on clear diagnostic criteria, has not been established. We present the case of a 48-year-old male patient, who was initially diagnosed with chronic mandibular osteomyelitis due to apical periodontitis in the right lower second premolar, and underwent antimicrobial medication and surgical therapy based on computed tomography (CT), magnetic resonance imaging (MRI), and bone scintigraphy.
View Article and Find Full Text PDF[Primary chronic osteomyelitis of the mandible in children: etiology and diagnostics].
Stomatologiia (Mosk)
December 2024
Peoples Friendship University of Russia, Moscow, Russia.
Primary chronic osteomyelitis (PCO) is a rare non-bacterial autoinflammatory severe disease that most often affects children aged 7 to 12 years and is much less common in adults. The most common areas of lesion are long tubular bones, however, any bones of the skeleton, including the lower jaw, can be affected. The clinical picture of this disease is complex and similar to many tumor and tumor-like bone lesions, which often leads to a significant delay in making a correct diagnosis.
View Article and Find Full Text PDFGARRE'S OSTEOMYELITIS OF LONG BONE IN ADULT.
J Ayub Med Coll Abbottabad
December 2024
Department of Orthopaedic, Ayub Medical College, Abbottabad-Pakistan.
Garre's osteomyelitis is a rare form of chronic osteomyelitis characterized by sclerosing and periosteal reaction of the affected bone. We report a case of a 35-year-old woman who presented with left tibial pain and swelling for 18 months. She was diagnosed with Garre's osteomyelitis of the mid-shaft tibia based on radiological and histopathological findings.
View Article and Find Full Text PDFThe discovery of migratory lesion in mandibular sclerosing osteomyelitis during biological inhibitors therapy: Two cases report and literature review.
J Stomatol Oral Maxillofac Surg
November 2024
Department of Stomatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730 China. Electronic address:
Article Synopsis
- Diffuse sclerosing osteomyelitis (DSO) in the mandible is a rare disease with unclear symptoms and varied treatment options, but the effectiveness of these treatments on bone repair is not fully understood.
- Two patients, a 37-year-old male and a 28-year-old female, were successfully treated with different biological inhibitors, leading to controlled symptoms and reduced inflammation, but the disease showed migratory behavior in their mandible lesions.
- The study suggests that rather than being caused by infections, periostitis might be a primary factor in the development of DSO, as evidenced by the movement of osteolytic lesions during treatment.
Improved quality of life after Ibandronic acid infusion in patients suffering from diffuse sclerosing osteomyelitis of the jaw.
Med Oral Patol Oral Cir Bucal
November 2024
Department of Oral and Maxillofacial Surgery University of Munich, Lindwurmstr. 2a D-80337 Munich, Germany
Article Synopsis
- A cross-sectional study investigated the impact of Ibandronic acid on quality of life in patients with diffuse sclerosing osteomyelitis, focusing on 34 subjective health parameters.
- 15 patients completed standardized questionnaires before and two weeks after receiving 6mg of Ibandronic acid, reporting various improvements.
- All patients noted significant enhancements in quality of life, including better oral health, reduced pain, improved fatigue and emotional functioning, as well as fewer speech and swallowing issues.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!